Your browser doesn't support javascript.
loading
MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain.
Samaranch, L; Blits, B; San Sebastian, W; Hadaczek, P; Bringas, J; Sudhakar, V; Macayan, M; Pivirotto, P J; Petry, H; Bankiewicz, K S.
Afiliação
  • Samaranch L; Department of Neurological Surgery, University of California, San Francisco, CA, USA.
  • Blits B; Neurobiology, Research and Development, UniQure NV, Amsterdam 1105BA, The Netherlands.
  • San Sebastian W; Department of Neurological Surgery, University of California, San Francisco, CA, USA.
  • Hadaczek P; Department of Neurological Surgery, University of California, San Francisco, CA, USA.
  • Bringas J; Department of Neurological Surgery, University of California, San Francisco, CA, USA.
  • Sudhakar V; Department of Neurological Surgery, University of California, San Francisco, CA, USA.
  • Macayan M; Department of Neurological Surgery, University of California, San Francisco, CA, USA.
  • Pivirotto PJ; Department of Neurological Surgery, University of California, San Francisco, CA, USA.
  • Petry H; Neurobiology, Research and Development, UniQure NV, Amsterdam 1105BA, The Netherlands.
  • Bankiewicz KS; Department of Neurological Surgery, University of California, San Francisco, CA, USA.
Gene Ther ; 24(4): 253-261, 2017 04.
Article em En | MEDLINE | ID: mdl-28300083
ABSTRACT
The present study was designed to characterize transduction of non-human primate brain and spinal cord with AAV5 viral vector after parenchymal delivery. AAV5-CAG-GFP (1 × 1013 vector genomes per milliliter (vg ml-1)) was bilaterally infused either into putamen, thalamus or with the combination left putamen and right thalamus. Robust expression of GFP was seen throughout infusion sites and also in other distal nuclei. Interestingly, thalamic infusion of AAV5 resulted in the transduction of the entire corticospinal axis, indicating transport of AAV5 over long distances. Regardless of site of injection, AAV5 transduced both neurons and astrocytes equally. Our data demonstrate that AAV5 is a very powerful vector for the central nervous system and has potential for treatment of a wide range of neurological pathologies with cortical, subcortical and/or spinal cord affection.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Primatas / Terapia Genética / Técnicas de Transferência de Genes / Vetores Genéticos Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Gene Ther Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Primatas / Terapia Genética / Técnicas de Transferência de Genes / Vetores Genéticos Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Gene Ther Ano de publicação: 2017 Tipo de documento: Article